UHCDS a-tDCS + TE in Fibromyalgia Patients

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

July 4, 2024

Study Completion Date

August 12, 2024

Conditions
Fibromyalgia
Interventions
DEVICE

Real UHCDS a-tDCS

Real UHCDS a-tDCS (STARTSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for ten sessions (three sessions per week in weeks 1 and 2; and one session per week in weeks 3, 4, 5 and 6). UHCDS a-tDCS is a galvanic current applied by a cap for 20 minutes at an intensity of 2 milliamps.

DEVICE

Sham UHCDS a-tDCS

Sham UHCDS a-tDCS (STARSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for ten sessions (three sessions per week in weeks 1 and 2; and one session per week in weeks 3, 4, 5 and 6). Sham tDCS will be applied for the same time than real UHCDS a-tDCS.

DEVICE

Therapeutic exercise

The therapeutic exercise program will include aerobic exercise and muscle strengthening in the same days as UHCDS a-tDCS. The program will last 30-45 minutes.

Trial Locations (1)

45600

Hospital General Nuestra Señora del Prado, Talavera de la Reina

All Listed Sponsors
lead

University of Castilla-La Mancha

OTHER

NCT06169748 - UHCDS a-tDCS + TE in Fibromyalgia Patients | Biotech Hunter | Biotech Hunter